The emerging role of vitamin D binding protein in multiple sclerosis

Journal of Neurology

Volumn 258, Issue 3, 2011, Pages 353-358

  Disanto, Giulio ^a,b   Ramagopalan, Sreeram V ^a,b,c   Para, Andrea E ^a,b   Handunnetthi, Lahiru ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cerebrospinal fluid; Disease course; Multiple sclerosis; Vitamin D binding protein

Indexed keywords

BIOLOGICAL MARKER; VITAMIN D BINDING PROTEIN;

CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC TEST; DISEASE COURSE; HUMAN; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RELAPSE; REVIEW;

ANIMALS; HUMANS; MULTIPLE SCLEROSIS; PROTEIN ISOFORMS; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 79953793105     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5797-8     Document Type: Review

References (50)

1. Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, Jacobs EJ, Ascherio A, Helzlsouer K, Jacobs KB, Li Q, Weinstein SJ, Purdue M, Virtamo J, Horst R, Wheeler W, Chanock S, Hunter DJ, Hayes RB, Kraft P, Albanes D (2010) Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 19:2739-2745
2. Almeras L, Eyles D, Benech P, Laffite D, Villard C, Patatian A, Boucraut J, Mackay-Sim A, McGrath J, Feron F (2007) Developmental vitamin D deficiency alters brain protein expression in the adult rat: implications for neuropsychiatric disorders. Proteomics 7:769-780 (Pubitemid 46450654)
3. Ascherio A, Munger KL, Simon KC (2010) Vitamin D and multiple sclerosis. Lancet Neurol 9:599-612
4. Bielekova B, Martin R (2004) Development of biomarkers in multiple sclerosis. Brain 127:1463-1478 (Pubitemid 38899400)
5. Bouillon R, Van Assche FA, Van Baelen H, Heyns W, De Moor P (1981) Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxy vitamin D3. Significance of the free 1,25-dihydroxy vitamin D3 concentration. J Clin Invest 67:589-596 (Pubitemid 11142347)
6. Chiasserini D, Di Filippo M, Candeliere A, Susta F, Orvietani PL, Calabresi P, Binaglia L, Sarchielli P (2008) CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis. Eur J Neurol 15:998-1001
7. Chun RF, Lauridsen AL, Suon L, Zella LA, Pike JW, Modlin RL, Martineau AR, Wilkinson RJ, Adams J, Hewison M (2010) Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab 95(7):3368-3376
8. Comabella M, Fernandez M, Martin R, Rivera-Vallve S, Borras E, Chiva C, Julia E, Rovira A, Canto E, Alvarez-Cermeno JC, Villar LM, Tintore M, Montalban X (2010) Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis. Brain 133:1082-1093
9. Cooke NE, Haddad JG (1989) Vitamin D binding protein (Gc-globulin). Endocr Rev 10:294-307 (Pubitemid 19223062)
10. Correale J, Ysrraelit MC, Gaitan MI (2009) Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 132:1146-1160
11. Daiger SP, Schanfield MS, Cavalli-Sforza LL (1975) Group-specific component (Gc) proteins bind vitamin D and 25- hydroxyvitamin D. Proc Natl Acad Sci USA 72:2076-2080
12. Dick IM, Prince RL, Kelly JJ, Ho KK (1995) Oestrogen effects on calcitriol levels in post-menopausal women: a comparison of oral versus transdermal administration. Clin Endocrinol (Oxf) 43:219-224
13. Dumont D, Noben JP, Raus J, Stinissen P, Robben J (2004) Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics 4:2117-2124 (Pubitemid 38880377)
14. Fernandes de Abreu DA, Eyles D, Feron F (2009) Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 34(Suppl 1):S265-S277
15. Giovannoni G (2010) Cerebrospinal fluid neurofilament: the biomarker that will resuscitate the 'Spinal Tap'. Mult Scler 16:285-286
16. Haddad JG, Fraser DR, Lawson DE (1981) Vitamin D plasma binding protein. Turnover and fate in the rabbit. J Clin Invest 67:1550-1560 (Pubitemid 11099372)
17. Hammack BN, Fung KY, Hunsucker SW, Duncan MW, Burgoon MP, Owens GP, Gilden DH (2004) Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult Scler 10:245-260 (Pubitemid 38807450)
18. Hayes CE, Cantorna MT, DeLuca HF (1997) Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med 216:21-27
19. Kamboh MI, Ferrell RE (1986) Ethnic variation in vitamin D-binding protein (GC): a review of isoelectric focusing studies in human populations. Hum Genet 72:281-293 (Pubitemid 16087987)
20. Kew RR, Webster RO (1988) Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg. J Clin Invest 82:364-369 (Pubitemid 18262540)
21. Klugmann M, Leichtlein CB, Symes CW, Klaussner BC, Brooks AI, Young D, During MJ (2006) A novel role of circadian transcription factor DBP in hippocampal plasticity. Mol Cell Neurosci 31:303-314 (Pubitemid 43214540)
22. Kurtzke JF (1980) Geographic distribution of multiple sclerosis: an update with special reference to Europe and the Mediterranean region. Acta Neurol Scand 62:65-80
23. Lauridsen AL, Vestergaard P, Hermann AP, Brot C, Heickendorff L, Mosekilde L, Nexo E (2005) Plasma concentrations of 25-hydroxy-vitamin D and 1, 25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int 77:15-22 (Pubitemid 41504168)
24. Lauridsen AL, Vestergaard P, Nexo E (2001) Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem 47:753-756 (Pubitemid 32275824)
25. Lehmensiek V, Sussmuth SD, Tauscher G, Brettschneider J, Felk S, Gillardon F, Tumani H (2007) Cerebrospinal fluid proteome profile in multiple sclerosis. Mult Scler 13:840-849 (Pubitemid 351540854)
26. Liu S, Bai S, Qin Z, Yang Y, Cui Y, Qin Y (2009) Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis. J Cell Mol Med 13:1586-1603
27. Mowry EM, Krupp LB, Milazzo M, Chabas D, Strober JB, Belman AL, McDonald JC, Oksenberg JR, Bacchetti P, Waubant E (2010) Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol 67:618-624
28. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296:2832-2838 (Pubitemid 44969183)
29. Niino M, Kikuchi S, Fukazawa T, Yabe I, Tashiro K (2002) No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS. J Neuroimmunol 127:177-179 (Pubitemid 34603589)
30. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938-952
31. Ottervald J, Franzen B, Nilsson K, Andersson LI, Khademi M, Eriksson B, Kjellstrom S, Marko-Varga G, Vegvari A, Harris RA, Laurell T, Miliotis T, Matusevicius D, Salter H, Ferm M, Olsson T (2010) Multiple sclerosis: identification and clinical evaluation of novel CSF biomarkers. J Proteomics 73:1117-1132
32. Pugliatti M, Sotgiu S, Rosati G (2002) The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 104:182-191 (Pubitemid 34792722)
33. Qin Z, Qin Y, Liu S (2009) Alteration of DBP levels in CSF of patients with MS by proteomics analysis. Cell Mol Neurobiol 29:203-210
34. Roussel BD, Macrez R, Jullienne A, Agin V, Maubert E, Dauphinot L, Potier MC, Plawinski L, Castel H, Hommet Y, Munuera J, Montaner J, Yepes M, Ali C, Vivien D (2009) Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact. Brain 132:2219-2230
35. Schneider GB, Benis KA, Flay NW, Ireland RA, Popoff SN (1995) Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations. Bone 16:657-662
36. Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, Soler D, Butcher EC (2007) DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 8:285-293
37. Sinotte M, Diorio C, Berube S, Pollak M, Brisson J (2009) Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr 89:634-640
38. Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R (2008) Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 14:1220-1224
39. Speeckaert M, Huang G, Delanghe JR, Taes YE (2006) Biological and clinical aspects of the vitamin D binding protein (Gcglobulin) and its polymorphism. Clin Chim Acta 372:33-42 (Pubitemid 44286753)
40. Steckley JL, Dyment DA, Sadovnick AD, Risch N, Hayes C, Ebers GC (2000) Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients. Canadian collaborative study group. Neurology 54:729-732 (Pubitemid 30082946)
41. Stoop MP, Dekker LJ, Titulaer MK, Lamers RJ, Burgers PC, Sillevis Smitt PA, van Gool AJ, Luider TM, Hintzen RQ (2009) Quantitative matrix-assisted laser desorption ionization-fourier transform ion cyclotron resonance (MALDI-FT-ICR) peptide profiling and identification of multiple-sclerosis-related proteins. J Proteome Res 8:1404-1414
42. Swamy N, Ghosh S, Schneider GB, Ray R (2001) Baculovirus-expressed vitamin D-binding protein-macrophage activating factor (DBP-maf) activates osteoclasts and binding of 25-hydroxyvitamin D(3) does not influence this activity. J Cell Biochem 81:535-546 (Pubitemid 32405771)
43. Tremlett H, van der Mei IA, Pittas F, Blizzard L, Paley G, Mesaros D, Woodbaker R, Nunez M, Dwyer T, Taylor BV, Ponsonby AL (2008) Monthly ambient sunlight, infections and relapse rates in multiple sclerosis. Neuroepidemiology 31:271-279
44. Tumani H, Lehmensiek V, Rau D, Guttmann I, Tauscher G, Mogel H, Palm C, Hirt V, Suessmuth SD, Sapunova-Meier I, Ludolph AC, Brettschneider J (2009) CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis. Neurosci Lett 452:214-217
45. von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C (2010) Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol 11:344-349
46. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, Kiel DP, Streeten EA, Ohlsson C, Koller DL, Peltonen L, Cooper JD, O'Reilly PF, Houston DK, Glazer NL, Vandenput L, Peacock M, Shi J, Rivadeneira F, McCarthy MI, Anneli P, de Boer IH, Mangino M, Kato B, Smyth DJ, Booth SL, Jacques PF, Burke GL, Goodarzi M, Cheung CL, Wolf M, Rice K, Goltzman D, Hidiroglou N, Ladouceur M, Wareham NJ, Hocking LJ, Hart D, Arden NK, Cooper C, Malik S, Fraser WD, Hartikainen AL, Zhai G, Macdonald HM, Forouhi NG, Loos RJ, Reid DM, Hakim A, Dennison E, Liu Y, Power C, Stevens HE, Jaana L, Vasan RS, Soranzo N, Bojunga J, Psaty BM, Lorentzon M, Foroud T, Harris TB, Hofman A, Jansson JO, Cauley JA, Uitterlinden AG, Gibson Q, Jarvelin MR, Karasik D, Siscovick DS, Econs MJ, Kritchevsky SB, Florez JC, Todd JA, Dupuis J, Hypponen E, Spector TD (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376:180-188
47. Xiao F, Chen D, Lu Y, Xiao Z, Guan LF, Yuan J, Wang L, Xi ZQ, Wang XF (2009) Proteomic analysis of cerebrospinal fluid from patients with idiopathic temporal lobe epilepsy. Brain Res 1255:180-189
48. Yamamoto N, Kumashiro R (1993) Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells. J Immunol 151:2794-2802 (Pubitemid 23264531)
49. Zhang J, Kew RR (2004) Identification of a region in the vitamin D-binding protein that mediates its C5a chemotactic cofactor function. J Biol Chem 279:53282-53287 (Pubitemid 40051832)
50. Zhang J, Sokal I, Peskind ER, Quinn JF, Jankovic J, Kenney C, Chung KA, Millard SP, Nutt JG, Montine TJ (2008) CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol 129:526-529 (Pubitemid 352029270)